RE:RE:RE:RE:RE:ASCO relevance
UPON APPROVAL Noteable , upon approval so how many times to I have to keep repeating this for you to understand. We do not have approval and therefore need to get the phase 3 trials underway in a timely manner and hopefully with a relatively smaller patient population which is possible with the biomarkers to help with all of this.
You do not always have to be so contentious all the time. It is just a free flow of information and concerns that are still justifiable and my simple point was that I would prefer a buyout over a partnership to remove all doubt for all of the shareholders. Pretty simple concept.
I of course am hoping for any deal after all of these years and we still do have AN in the background which appeears to be waiting on ASCO and I am sure that their sites will most likely already be in place.
We will know when we know and that will only be when an announcement is made.